Back to Search
Start Over
Endologix Announces Results of Pooled Analysis of DETOUR1 and DETOUR2 Studies at 2023 VIVA Late-Breaking Clinical Trial Session
- Source :
- Business Wire. November 2, 2023
- Publication Year :
- 2023
-
Abstract
- IRVINE, Calif. -- Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, today announced results from a pooled [...]
- Subjects :
- Clinical trials
Blood circulation disorders
Business
Business, international
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Business Wire
- Publication Type :
- News
- Accession number :
- edsgcl.771159340